Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 29, 2025

Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses
10:45

Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses

Published on: June 13, 2018

11.2K

Calciphylaxis: A Deceiving Cellulitis.

Sreenath Meegada1, Madhavi Annakula1, Tejo Challa1

  • 1Internal Medicine, The University of Texas Health Science Center/Christus Good Shepherd Medical Center, Longview, USA.

Cureus
|February 7, 2020
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

308
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
308

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Industry payments to hospitalist physicians: a 5-year analysis of the Open Payments programme from 2014 to 2018.

Internal medicine journal·2020
Same author

Recurrent Cholangiocarcinoma Presenting as Sister Mary Joseph Nodule After Liver Transplantation.

Cureus·2020
Same author

Coronavirus Disease 2019-Induced Rhabdomyolysis.

Cureus·2020
Same author

Guillain-Barre Syndrome and Syndrome of Inappropriate Antidiuretic Hormone (SIADH) Secretion as Paraneoplastic Syndromes in Splenic Marginal B-cell Non-Hodgkins Lymphoma: A Rare Presentation.

Cureus·2020
Same author

Albuterol-Induced Type B Lactic Acidosis: Not an Uncommon Finding.

Cureus·2020
Same author

Staphylococcus warneri: Skin Commensal and a Rare Cause of Urinary Tract Infection.

Cureus·2020

Calciphylaxis, a rare condition in dialysis patients, involves calcium deposits in skin blood vessels, causing painful lesions. Early recognition is crucial for appropriate treatment of this serious disorder.

Area of Science:

  • Nephrology
  • Dermatology
  • Vascular Biology

Background:

  • Calciphylaxis is a rare, severe condition predominantly affecting end-stage renal disease (ESRD) patients undergoing dialysis.
  • It is characterized by calcification of small and medium-sized blood vessels in the skin and subcutaneous fat.

Observation:

  • Patients present with painful skin lesions, including plaques, ulcerations, and gangrene.
  • These lesions can lead to secondary infections, increasing morbidity and mortality.

Findings:

  • The underlying mechanism involves calcium deposition in dermal and subcutaneous vasculature.
  • This vascular compromise results in tissue ischemia and necrosis.

Implications:

  • Increased awareness among healthcare providers is essential for timely diagnosis.
Keywords:
calciphylaxiscellulitisend stage renal disease

Related Experiment Videos

Last Updated: Dec 29, 2025

Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses
10:45

Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses

Published on: June 13, 2018

11.2K
  • Considering calciphylaxis in the differential diagnosis of cellulitis in at-risk patients can improve patient outcomes.
  • Further research into the pathogenesis and treatment of calciphylaxis is warranted.